Careers  |  Sign In  |  Register

Latest in Pharmacists

Reuters Health • The Doctor's Channel Daily Newscast

Generalized anxiety disorder needs long-term treatment: study

NEW YORK (Reuters Health) - Patients with generalized anxiety disorder (GAD) are best treated with an antidepressant for at least 12 months, according to a study published in the December Archives of General Psychiatry. Dr. Karl Rickels and colleagues from the Mood and Anxiety Disorders Section of the...

Reuters Health • The Doctor's Channel Daily Newscast

Rizatriptan may work for migraineurs who don’t respond to sumatriptan

NEW YORK (Reuters Health) - Patients with acute migraine who find sumatriptan ineffective may have a better response to rizatriptan, according to a study reported in Cephalalgia online November 15. In their introduction, the authors note that up to 40% of migraine patients do not respond to sumatriptan,...

Reuters Health • The Doctor's Channel Daily Newscast

Tea extract improves symptoms of schizophrenia

NEW YORK (Reuters Health) - Augmenting antipsychotic treatment with a biologically active natural product, L-theanine, improves symptoms in patients with schizophrenia or schizoaffective disorder, Israeli investigators have shown in a study reported in the Journal of Clinical Psychiatry online November...